TheraPanacea, an award-winning medical technology company created in 2017, is reinventing healthcare through harnessing AI to develop cutting-edge software to optimize diagnostics, prognostics and therapies for cancer and other complex diseases.
We offer pioneering holistic approaches for cancer research and treatment based on a multi-scale integration of medicine, information theory, data curation and computational medicine.
At TheraPanacea we are devoted to unlock the unlimited power of AI-based software to drive innovation in healthcare. Endowed with an excellent IP portfolio, our vision is to exploit state-of-the-art research technology to accelerate health care’s transition towards predictive, evidence-driven, adaptive treatment planning and delivery.
Our mission is to improve patient’s quality of life by enabling health care providers to design smarter treatment plans, work more effectively, and reduce toxic side effects. To bring these much needed advancements faster to the patient, we count on a multitude of collaborations with leading cancer centers and industrial partners all around the world.
For more information about the company please visit https://www.therapanacea.eu/.
Minimum level required: Master degree in engineering or biomedical domain in progress
Required skills:
Language:
French / Fluent English